Decade after Georgia lawmakers legalized low-THC medical cannabis, Legislature weighs broader access
Ten years after Georgia legalized cannabis possession for medical use, lawmakers in both chambers of the state Legislature ...
Cormark upgraded Trulieve Cannabis (TCNNF) to Speculative Buy from Market Perform with a C$15 price target Discover the Best Stocks and ...
Following the company’s fourth quarter results, Ventum Capital Markets analyst Andrew Semple has cut his price target on ...
Trulieve Cannabis Corp. (OTCQX:TCNNF) reported a revenue of $301.1 million, surpassing estimates and indicating a 5% year-over-year growth. The company’s gross margin improved significantly to 62%, up ...
Trulieve is betting the farm on its new drinks, while GTI keeps regulatorily risky hemp operations at arm's length.
Haywood analyst Neal Gilmer maintained a Buy rating on Trulieve Cannabis (TCNNF – Research Report) today and set a price target of C$15.00. The ...
3d
Metro US on MSNPennsylvania’s path to cannabis legalization — challenges, politics and the road aheadAfter a long, largely successful march over 25 years to liberalize cannabis laws in the United States, the movement had a ...
Trulieve’s medical director, Dr. William Troutt, says pickleball and cannabis share many similarities. : Pickleball has been growing more popular with older people, and Troutt said he is seeing the ...
Trulieve Cannabis Corp (TCNNF) reports a 5% increase in full-year revenue and strategic retail expansion, despite facing ...
Fourth quarter revenue of $301 million, up 5% year over year, exceeding guidance Gross margin of 62%, compared to 54% during the fourth quarter of 2023 Record ...
You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since ...
Trulieve Cannabis Corp. (PNK:TCNNF) is set to release its quarterly earnings with an expected EPS of -$0.18 and revenue of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results